Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-02 4:47 pm Purchase | 2026-03-26 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | RA CAPITAL MANAGEMENT LLC | 2,078,913 9.900% | 2,078,913 (New Position) | Filing History |
| 2026-04-02 4:26 pm Purchase | 2026-03-26 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | COMMODORE CAPITAL LP | 1,950,000 9.900% | 1,820,959 (+1411.15%) | Filing History |
| 2026-02-17 10:28 am Sale | 2025-12-31 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | T. Rowe Price Investment Management, Inc. | 2,244,421 11.800% | -59,821 (-2.60%) | Filing History |
| 2026-02-12 09:03 am Sale | 2025-12-31 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Adage Capital Management, L.P. | 436,736 2.380% | -1 (-0.00%) | Filing History |
| 2026-02-10 4:48 pm Purchase | 2026-02-04 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | INTEGRATED CORE STRATEGIES (US) LLC | 1,008,662 5.500% | 1,007,762 (+111973.56%) | Filing History |
| 2026-01-29 9:32 pm Purchase | 2026-01-22 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Affinity Asset Advisors LLC | 1,713,092 8.600% | 1,048,868 (+157.91%) | Filing History |
| 2025-11-14 10:45 am Purchase | 2025-09-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 649,984 4.900% | 325 (+0.05%) | Filing History |
| 2025-11-07 1:02 pm Purchase | 2025-10-31 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | T. Rowe Price Investment Management, Inc. | 2,304,242 13.800% | 1,575,476 (+216.18%) | Filing History |
| 2025-11-03 4:30 pm Purchase | 2025-10-14 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | J. Wood Capital Advisors LLC | 1,000,708 4.990% | 542,573 (+118.43%) | Filing History |
| 2025-10-30 3:18 pm Sale | 2025-09-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | VANGUARD GROUP INC | 408,222 4.700% | -102,077 (-20.00%) | Filing History |
| 2025-10-17 4:05 pm Purchase | 2025-10-10 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Opaleye Management Inc. | 1,569,002 9.480% | 1,569,002 (New Position) | Filing History |
| 2025-10-17 1:55 pm Sale | 2025-09-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | JPMORGAN CHASE & CO JPM | 0 0.000% | -450,436 (Position Closed) | Filing |
| 2025-08-14 12:12 pm Purchase | 2025-06-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | T. Rowe Price Investment Management, Inc. | 728,766 8.400% | 728,766 (New Position) | Filing History |
| 2025-07-16 09:34 am Purchase | 2025-06-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | JPMORGAN CHASE & CO JPM | 450,436 5.200% | 450,436 (New Position) | Filing History |
| 2025-04-10 5:23 pm Purchase | 2025-04-03 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Affinity Asset Advisors LLC | 664,224 7.830% | 664,224 (New Position) | Filing History |
| 2025-02-12 09:36 am Purchase | 2024-12-31 | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Adage Capital Management, L.P. | 436,737 5.180% | 436,737 (New Position) | Filing History |
| 2024-11-14 4:22 pm Sale | 2024-09-30 | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Avidity Partners Management LP | 316,071 3.700% | -429,845 (-57.63%) | Filing History |
| 2024-11-12 3:50 pm Unchanged | 2024-09-30 | 13G | KARYOPHARM THERAPEUTICS INC KPTI | VANGUARD GROUP INC | 510,299 6.130% | 0 (Unchanged) | Filing History |
| 2024-11-04 11:49 am Sale | 2024-09-30 | 13G | KARYOPHARM THERAPEUTICS INC KPTI | VANGUARD GROUP INC | 510,299 6.130% | -70,378 (-12.12%) | Filing History |
| 2024-10-25 09:30 am Purchase | 2024-09-30 | 13G | KARYOPHARM THERAPEUTICS INC KPTI | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 649,659 7.200% | 649,659 (New Position) | Filing History |